Sponsored Content
- Sponsored Content
Production of Biotherapeutics Using GlycoExpress® Expression Platform Technology
1 Min Read
Sponsored by Glycotope
GlycoExpress® (GEX®) technology is a well-established human expression platform for the screening and production of biotherapeutics. By contrast with other human cell lines (e.g., HEK293 and Per.C6) GlycoExpress® expression platform consists of a toolbox of glycoengineered cell lines optimized for producing biotherapeutics with desired glycan structures to improve their clinical performance.
Glycotope’s GEX® technology provides an established expression platform proven for different biopharmaceuticals:
Antibodies of different isotypes (e.g., IgG, IgM, IgA)
Defucosylated antibodies
Bispecific antibodies/fragments (e.g., NK cell/T-cell recruiters)
Difficult-to-express and complex glycosylated proteins
Blood factors (e.g., FVII)
Protein hormones (e.g., FSH, HCG)
Fusion proteins with extended serum half-life
Enzymes (e.g., for enzyme replacement therapy).
Login to read the full PDF of the application note.
You May Also Like
Sponsored Content
Jun 5 - Jun 6, 2024
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More
